Orchid Pharma is currently trading at Rs. 64.80, up by 3.10 points or 5.02 % from its previous closing of Rs. 61.70 on the BSE.
The scrip opened at Rs. 63.00 and has touched a high and low of Rs. 66.40 and Rs. 62.70 respectively. So far 817152 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 75.30 on 06-Aug-2015 and a 52 week low of Rs. 42.60 on 11-Jun-2015.
Last one week high and low of the scrip stood at Rs. 62.90 and Rs. 51.10 respectively. The current market cap of the company is Rs. 580.94 crore.
The promoters holding in the company stood at 44.04 % while Institutions and Non-Institutions held 5.28 % and 46.89 % respectively.
Orchid Pharma’s wholly-owned subsidiary - Orchid Europe, UK, has entered into a long term financial arrangement to avail up to $800 million as loan with Line Trust International, Guernsey, UK. This funding will help the company explore new growth opportunities while enabling the current business achieve incremental value.
Orchid Chemicals & Pharmaceuticals is a pharmaceutical company engaged in development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs. The company was incorporated in the year 1992 as a 100% export-oriented unit (EOU).
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |